文献
J-GLOBAL ID:201802228867096343
整理番号:18A1728192
コパキシンと比較したヨーロッパにおけるフォロー-オン・グラチラムアセタート製品の物理化学的,生物学的,機能的および毒物学的特性化【JST・京大機械翻訳】
Physicochemical, biological, functional and toxicological characterization of the European follow-on glatiramer acetate product as compared with Copaxone
著者 (24件):
Melamed-Gal S.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Loupe P.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Timan B.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Weinstein V.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Kolitz S.
(Immuneering Corporation, Boston, MA, USA)
,
Zhang J.
(Immuneering Corporation, Boston, MA, USA)
,
Funt J.
(Immuneering Corporation, Boston, MA, USA)
,
Komlosh A.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Ashkenazi N.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Bar-Ilan O.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Konya A.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Beriozkin O.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Laifenfeld D.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Hasson T.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Krispin R.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Molotsky T.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Papir G.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Sulimani L.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Zeskind B.
(Immuneering Corporation, Boston, MA, USA)
,
Liu P.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Nock S.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Hayden M.R.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Gilbert A.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
,
Grossman I.
(Global Research and Development, Teva Pharmaceutical Industries, Netanya, Israel)
資料名:
eNeurologicalSci
(eNeurologicalSci)
巻:
12
ページ:
19-30
発行年:
2018年
JST資料番号:
W3093A
ISSN:
2405-6502
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)